Headlands Technologies LLC Increases Position in ASP Isotopes Inc. $ASPI

Posted by Brenda Bartman on Sep 1st, 2026

Headlands Technologies LLC raised its holdings in ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) by 219.6% in the 2nd quarter, HoldingsChannel reports. The fund owned 240,197 shares of the company’s stock after acquiring an additional 165,031 shares during the period. Headlands Technologies LLC’s holdings in ASP Isotopes were worth $1,494,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Mercer Global Advisors Inc. ADV lifted its position in shares of ASP Isotopes by 8.3% during the third quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock worth $203,000 after purchasing an additional 1,622 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in ASP Isotopes by 9.9% during the second quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock valued at $153,000 after purchasing an additional 1,878 shares during the last quarter. Legal & General Group Plc raised its position in shares of ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after purchasing an additional 1,953 shares during the period. The Manufacturers Life Insurance Company lifted its stake in ASP Isotopes by 8.8% in the first quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock valued at $135,000 after buying an additional 2,470 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its stake in ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after purchasing an additional 2,548 shares during the period. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Trading Up 3.6%

ASP Isotopes stock opened at $4.02 on Tuesday. The company’s fifty day simple moving average is $4.59 and its 200-day simple moving average is $5.24. The company has a quick ratio of 3.85, a current ratio of 3.87 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a 12 month low of $3.51 and a 12 month high of $14.49. The stock has a market cap of $616.31 million, a P/E ratio of -3.05 and a beta of 3.61.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The firm had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.

Wall Street Analyst Weigh In

ASPI has been the topic of a number of recent analyst reports. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $13.00.

Check Out Our Latest Report on ASPI

Insider Buying and Selling

In other ASP Isotopes news, Director Todd Wider sold 50,000 shares of the company’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $6.25, for a total value of $312,500.00. Following the transaction, the director directly owned 722,247 shares of the company’s stock, valued at $4,514,043.75. This represents a 6.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Paul Elliot Mann sold 83,759 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $7.76, for a total value of $649,969.84. Following the sale, the chief executive officer directly owned 9,579,845 shares of the company’s stock, valued at $74,339,597.20. This trade represents a 0.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 195,321 shares of company stock worth $1,354,855. Insiders own 14.40% of the company’s stock.

About ASP Isotopes

(Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.